OvaScience is a company focused on the discovery, development and commercialization of new treatment options for women and families struggling with infertility. Specifically, we are developing cell therapies for infertility and are seeking outstanding scientists to join our team. We are developing these treatments through the generation of developmentally competent human oocytes in vitro from a woman’s own Egg Precursor (EggPCSM) cell. These oocytes will have the potential to develop into normal embryos and thus address the unmet medical need for the generation of new eggs for patients who are unable to undergo conventional in vitro fertilization (IVF) treatments and have their own biological child.
OvaScience is looking for a Scientist/Sr. Scientist to join our Research team. This position, based in Waltham, MA, will be responsible for developing new approaches to differentiate EggPC cells into fertilizable eggs. S/he will bring subject matter and bench level expertise to design, execute and interpret experiments that combine stem cell expertise, tissue regeneration expertise, bioengineering expertise and/or reproductive biology expertise to engineer the maturation process in vitro.
Must be a highly driven, self-directed, independent research scientist able to develop new ideas into successful research projects.
Candidates must be authorized to work in the United States. OvaScience offers competitive salaries and benefits including medical, dental, and vision coverage, a 401(k) plan with company match, stock options, education assistance, time off, and other wellness initiatives.
OvaScienceSM, Inc. (NASDAQ:OVAS) is a company focused on the discovery, development and commercialization of new treatment options for women and families struggling with infertility. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of egg precursor (EggPCSM) cells – immature egg cells found inside the protective ovarian lining. OvaScience is developing OvaPrimeSM, which could increase a woman’s egg reserve and OvaTureSM, a potential in vitro fertilization (IVF) treatment that could help a woman produce new, fertilizable eggs without hormone injections. OvaScience’s AUGMENTSM treatment, a fertility option designed to improve IVF success rates, is available in certain IVF clinics in Canada and Japan. OvaScience treatments are not available in the U.S. For more information, visit www.ovascience.com.